Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹71.4 Cr -3.7% 0.8% -43.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,224.8 Cr -5% 5.4% -3.4% Stock Analytics
KIRI INDUSTRIES ₹2,746.6 Cr -0.1% -11.1% -21.8% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,592.8 Cr 2.9% -2.7% -29.9% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,147.2 Cr 1.6% 8.1% 26.7% Stock Analytics
BODAL CHEMICALS ₹605.2 Cr -5.3% -2% -24.7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.7%

0.8%

-43.1%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses